share_log
Reuters ·  Mar 14 11:25
TScan Therapeutics Inc : Morgan Stanley Assumes Coverage With Overweight Rating; Price Target $10
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 251

Recommended

Write a comment